Methamphetamine Stabilization Programs by State

39 programs across 1 states provide medically monitored methamphetamine detox, all operating under ASAM Criteria with 24/7 psychiatric observation, cardiac telemetry where indicated, suicide-risk monitoring through the first 7-10 days, and a planned step-down into contingency management or the Matrix Model 16-week IOP.

Meth withdrawal is not medically lethal in itself, but the suicide-risk window during the depression-anhedonia trough stretches across the first 1-2 weeks (wider than with cocaine), cardiac complications from chronic heavy use can surface during the acute window, persistent stimulant-induced psychotic symptoms are dangerous in their own right, and fentanyl- and xylazine-contaminated meth supply means the post-crash relapse window now carries direct overdose risk. Inpatient stabilization with psychiatric observation, telemetry where indicated, antipsychotic management where psychosis persists, and naloxone at discharge lowers that risk substantially.

5-7 days inpatient is the standard window for crash-phase and early-withdrawal stabilization — longer than cocaine because the acute psychiatric window stretches further, shorter than alcohol or opioid detox because there is no withdrawal-medication taper to manage. Heavy daily users, polysubstance cases, persistent stimulant-induced psychosis, active psychiatric crises, and cardiac involvement can stretch the stay to 10-14 days. Programs follow psychiatric resolution and Matrix Model or contingency-management IOP induction readiness rather than a fixed calendar.

There is no FDA-approved medication for methamphetamine use disorder, so the regimen is supportive rather than substance-specific — mirtazapine or trazodone for sleep, hydroxyzine for anxiety, second-generation antipsychotics (olanzapine, risperidone, quetiapine) where stimulant-induced psychotic symptoms surface or persist, SSRIs or SNRIs for depression that runs past the first two weeks, and naloxone at discharge for the fentanyl- and xylazine-contamination risk. Bupropion and the naltrexone-bupropion combination have been studied with limited efficacy in selected cases but are not standard of care.

Most insurers do — Medicaid in all 50 states, most major private plans under ACA parity rules, Medicare in many situations, and Tricare for military families. SAMHSA-funded slots fill the gap for uninsured admissions, and community-based nonprofits often hold aside grant-funded beds for stimulant work where federal funding underwrites a meaningful share of capacity. Hudson Mohawk Recovery has held that capacity in the Capital District since 1967.

Stabilization is the start, not the whole job — the protracted withdrawal phase that follows (months of episodic cravings, lingering anhedonia, cognitive and executive-function deficits in heavy chronic users, occasional return of low-grade psychotic features) is where most relapses happen. From there, clients step into contingency management (the behavioral intervention with the strongest evidence base for any stimulant use disorder), the Matrix Model (a manualized 16-week IOP designed specifically for stimulants), residential (28-90 days), or IOP/PHP outpatient (8-12 weeks) depending on severity, support system, and psychiatric comorbidity. CMA (Crystal Meth Anonymous), NA, SMART Recovery, and peer recovery centers carry the work forward at home.